Edesa Biotech (EDSA) Metrics: History & Chart

Edesa Biotech, Inc.(EDSA)

Biotechnology · Markham, ON

$3.93+0.01 (+0.38%)

Delayed quote: Oct 6, 2026, 10:02 AM EDT

About Edesa Biotech, Inc.

Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.

Markham, ON

17 employees

www.edesabiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Pardeep Nijhawan

View full financials

Third-Party DCF Estimate (FMP)	$2.00
Price Gap vs Third-Party Estimate	-48.75%

7D Total Return	+7.12%
30D Total Return	-17.34%
YTD Total Return	+175.35%
1Y Total Return	+52.73%
3Y Total Return	-11.34%
5Y Total Return	-92.14%
10Y Total Return	-99.43%
15Y Total Return	-99.69%
20Y Total Return	N/A

2026	+175.35%
2025	-15.48%
2024	-63.24%
2023	-69.78%
2022	-61.63%
2021	+32.47%
2020

CAGR TTM	+52.43%
CAGR 3Y	-3.93%
CAGR 5Y	-39.88%
CAGR 10Y	-40.32%
CAGR 15Y	-31.97%
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

EDSA Valuation Metrics

EDSA Stock Price Metrics

EDSA Dividend Metrics

EDSA Growth Rate Metrics

EDSA Discounted Cash Flow Metrics

EDSA Returns By Period

EDSA Yearly Returns

EDSA Average Annual Returns By Period (CAGR)

EDSA Revenue Metrics

EDSA PE Ratio Metrics

EDSA PS Ratio Metrics

EDSA PB Ratio Metrics

EDSA Price to Free Cash Flow Ratio Metrics

EDSA Debt to Equity Ratio Metrics

EDSA PEG Ratio Metrics

EDSA FCF Yield

EDSA Earnings Yield

EDSA EBITDA Yield

EDSA OCF Yield

EDSA EV/EBIT Ratio Metrics

EDSA EV/EBITDA Ratio Metrics

EDSA EV/Assets Ratio Metrics

EDSA EV/Sales Ratio Metrics

EDSA Current Ratio Metrics

EDSA Quick Ratio Metrics

EDSA ROIC Metrics

EDSA Return on Assets Metrics

EDSA Return on Equity Metrics

EDSA Net Profit Margin Metrics

EDSA Gross Profit Margin Metrics

EDSA Tax Rate Metrics

PS Ratio	155843.45
PS Ratio Avg TTM	65299.11
PS Ratio Avg 3Y	115.58
Current VS TTM Avg	+138.66%
Current VS 3Y Avg	+134739.26%
Current VS 5Y Avg	+168029.61%

PB Ratio	88.27
PB Ratio Avg TTM	14.23
PB Ratio Avg 3Y	3.39
Current VS TTM Avg	+520.29%
Current VS 3Y Avg	+2506.03%
Current VS 5Y Avg	+2860.13%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	N/A
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.96
Ev/Assets Ratio Avg TTM	2.56
Ev/Assets Ratio Avg 3Y	1.53
Current VS TTM Avg	-23.33%
Current VS 3Y Avg	+28.10%
Current VS 5Y Avg	+33.70%

Ev/Sales Ratio	139980.76
Ev/Sales Ratio Avg TTM	59371.36
Ev/Sales Ratio Avg 3Y	105.53
Current VS TTM Avg	+135.77%
Current VS 3Y Avg	+132541.88%
Current VS 5Y Avg	+200650.47%

Current Ratio	2.76
Current Ratio Avg TTM	10.80
Current Ratio Avg 3Y	6.60
Current VS TTM Avg	-74.46%
Current VS 3Y Avg	-58.21%
Current VS 5Y Avg	-49.20%

Quick Ratio	2.76
Quick Ratio Avg TTM	10.80
Quick Ratio Avg 3Y	6.60
Current VS TTM Avg	-74.46%
Current VS 3Y Avg	-58.21%
Current VS 5Y Avg	-49.20%

ROIC	(166.02%)
ROIC Avg 3Y	(156.58%)
ROIC Avg 5Y	(142.99%)
Current VS 3Y Avg	-6.02%
Current VS 5Y Avg	-16.11%
Current VS 10Y Avg	-64.40%

ROA	(110.85%)
ROA Avg TTM	(24.00%)
ROA Avg 3Y	(24.29%)
Current VS TTM Avg	-361.96%
Current VS 3Y Avg	-356.43%
Current VS 5Y Avg	-342.36%

ROE	(160.05%)
ROE Avg TTM	(83.61%)
ROE Avg 3Y	(139.81%)
Current VS TTM Avg	-91.41%
Current VS 3Y Avg	-14.48%
Current VS 5Y Avg	-32.31%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	1.90%
Tax Rate Avg 3Y	1.20%
Tax Rate Avg 5Y	1.20%
Current VS 3Y Avg	+58.79%
Current VS 5Y Avg	+58.79%
Current VS 10Y Avg	+58.79%